(Q44601055)

4 December 2017

title

Inhibition of influenza virus infections in immunosuppressed mice with orally administered peramivir (BCX-1812). (English)

1 reference

4 December 2017

1 reference

R W Sidwell

1

1 reference

4 December 2017

K W Bailey

2

1 reference

4 December 2017

J D Morrey

3

1 reference

4 December 2017

M H Wong

4

1 reference

4 December 2017

T J Baldwin

5

1 reference

4 December 2017

D F Smee

6

1 reference

4 December 2017

publication date

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

60

1 reference

4 December 2017

issue

1

1 reference

4 December 2017

page(s)

17-25

1 reference

Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900113-X

7 January 2021

Some clinical laboratory briefs on staphylococci

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900113-X

7 January 2021

Cells mediating delayed-type hypersensitivity in the lungs of mice infected with an influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900113-X

7 January 2021

Influenza A in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900113-X

7 January 2021

The Pathogenesis of Infections of the Mouse Caused by Virulent and Avirulent Variants of an Influenza Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900113-X

7 January 2021

Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900113-X

7 January 2021

Genetically determined murine models of immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900113-X

7 January 2021

Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900113-X

7 January 2021

In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900113-X

7 January 2021

Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900113-X

7 January 2021

Progressive Murine Cytomegalovirus Disease after Termination of Ganciclovir Therapy in Mice Immunosuppressed by Cyclophosphamide Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900113-X

7 January 2021

Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900113-X

7 January 2021

Oral administration of cyclopentane neuraminidase inhibitors protects ferrets against influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900113-X

7 January 2021

Effects of low- and high-passage influenza virus infection in normal and nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2803%2900113-X

7 January 2021

10.1016/S0166-3542(03)00113-X

Identifiers

DOI

1 reference

4 December 2017

1 reference